Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan

The HIV-1 envelope (Env) glycoprotein is the primary target of the humoral immune response and a critical vaccine candidate. However, Env is densely glycosylated and thereby substantially protected from neutralisation. Importantly, glycan N301 shields V3 loop and CD4 binding site epitopes from neutr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Roux-Cil, Grant, Oliver C., Moyo, Thandeka, Dorfman, Jeffrey R., Woods, Robert J., Travers, Simon A., Wood, Natasha T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177452/
https://www.ncbi.nlm.nih.gov/pubmed/30302011
http://dx.doi.org/10.1038/s41598-018-33390-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177452/
https://www.ncbi.nlm.nih.gov/pubmed/30302011
http://dx.doi.org/10.1038/s41598-018-33390-2

Ejemplares similares